Skip to main content

iwCLL 2025 Main banner

iwCLL X / Twitter

103 Views

Poster

1410 - Impact of testing for genetic markers on treatment selection and clinical outcomes among patients with chronic lymphocytic leukemia

Primary Author / Presenter(s)

Brian Koffman, MD

Co-Founder, Executive Vice President, Chief Medical Officer
CLL Society, Inc., Chula Vista
Claremont, California, United States

Co-Author(s)

XW

Xiaoliang Wang, PhD, MPH

BeOne Medicines Ltd
San Carlos, California, United States
QF

Qianhong Fu, MS

BeOne Medicines Ltd
San Carlos, California, United States
DY

Dong Yuan, PhD

BeOne Medicines Ltd
San Carlos, California, United States
Dv

Derrick van Beuge, PharmD

BeOne Medicines Ltd
San Carlos, California, United States
GM

Gregory A Maglinte, PhD, MPH

BeOne Medicines Ltd
San Carlos, California, United States
ES

Erlene K Seymour, MD

BeOne Medicines Ltd
San Carlos, California, United States